Hurley, Michael J;
Bates, Rachel;
Macnaughtan, Jane;
Schapira, Anthony HV;
(2022)
Bile acids and neurological disease.
Pharmacology & Therapeutics
, 240
, Article 108311. 10.1016/j.pharmthera.2022.108311.
Preview |
Text
1-s2.0-S0163725822002054-main.pdf - Published Version Download (1MB) | Preview |
Abstract
This review will focus on how bile acids are being used in clinical trials to treat neurological diseases due to their central involvement with the gut-liver-brain axis and their physiological and pathophysiological roles in both normal brain function and multiple neurological diseases. The synthesis of primary and secondary bile acids species and how the regulation of the bile acid pool may differ between the gut and brain is discussed. The expression of several bile acid receptors in brain and their currently known functions along with the tools available to manipulate them pharmacologically are examined, together with discussion of the interaction of bile acids with the gut microbiome and their lesser-known effects upon brain glucose and lipid metabolism. How dysregulation of the gut microbiome, aging and sex differences may lead to disruption of bile acid signalling and possible causal roles in a number of neurological disorders are also considered. Finally, we discuss how pharmacological treatments targeting bile acid receptors are currently being tested in an array of clinical trials for several different neurodegenerative diseases.
Archive Staff Only
 |
View Item |
